Ingrid Torjesen
Impaired taste and smell may explain poor nutrition in psoriasis patients
Psoriasis has long been linked with poor nutrition, high body mass index and metabolic disorders. New research suggests a reduced sense of taste and smell, caused by inflammation, may explain why.
Genetic variation may explain why biologics help some patients, but fail others
Psoriasis patients carrying a specific gene experience a significantly better early response to ustekinumab, but are less likely to achieve high rates of response to anti-TNFs.
Cardiovascular disease in psoriasis may be due to a cardiosplenic axis
The spleen may have a role in driving the higher rate of cardiovascular disease seen in psoriasis patients through a spleen–atherosclerotic axis, suggests research presented at a meeting in London.
Diet and lifestyle factors may trigger psoriasis
Environmental and lifestyle factors, such as certain foods and infections, may trigger onset of psoriasis and account for approximately 30% of the risk of the condition in people with a genetic preposition, research presented in London shows.
Hard-to-treat psoriasis cases respond to secukinumab
Secukinumab has been shown to be effective for the treatment of moderate-to-severe plaque psoriasis in hard-to-treat patients who failed anti-TNFa treatment, researchers report in London.
Promising results for risankizumab continue in phase 3 trials
Phase three trials of the selective IL-23 blocker risankizumab are replicating the promising results achieved by phase two trials for psoriasis, researchers report in London.
Restarting TNFi treatment after a break proves beneficial in psoriasis
Switching from adalimumab to etanercept or vice versa after interruption can improve treatment response, data presented in London suggests.
Psoriasis patients have a heightened risk of malignant lymphoma
Patients with psoriasis are more likely than the general population to receive a diagnosis of malignant lymphoma. Why? Cutaneous T-cell lymphoma is misdiagnosed as psoriasis and can also be mistaken for atopic dermatitis due to similarities in the skin manifestation.
Caffeine can reduce inflammation in patients with eczema and psoriasis
Adding caffeine to topical skin treatments would be a simple way to reduce inflammation in patients with atopic dermatitis and psoriasis, suggests a review presented at the Psoriasis: From Gene to Clinic International Congress, which took place in London this week.

Poll

View Results